AEST-ETHICA Trademark

Trademark Overview


On Thursday, May 11, 2023, a trademark application was filed for AEST-ETHICA with the United States Patent and Trademark Office. The USPTO has given the AEST-ETHICA trademark a serial number of 97931030. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, May 22, 2024. This trademark is owned by Ethica CRO Inc.. The AEST-ETHICA trademark is filed in the Advertising, Business and Retail Services, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

Contract research services for clinical trials, namely, conducting investigator meetings; clinical trial management services, namely, study-specific clinical personnel training programs for investigators and coordinators, investigator meetings

Contract research services for clinical trials, namely, recruiting investigators, providing strategies for recruitment of participants, screening participants; clinical trial management services, namely, : pre-study document collection and review, site selection, pre-study site visits, initiation visits, monitoring visits, closeout visits, project tracking and monitoring reports, negotiation and administration of investigator grants, labelling, packaging, distribution, coordination and tracking of clinical trial materials, regulatory document processing, central laboratory selection and coordination; clinical trial management services, namely, site and study-specific participant recruitment strategies and programs, namely, contingency strategies and solutions to address specific project challenges, development of all study related documents and materials, namely, study protocols, amendments, case report forms (paper or electronic), informed consent forms, study operations/monitoring ma...

Contract research services for clinical trials, namely, developing study protocols, designing case report forms; developing complete databases in accordance with strict guidelines, cordinating ethics review submissions, developing and maintaining trial master file (paper or electronic), tracking of study parameters, providing statistical analyses and reporting; development of tracking tools for enrollment, essential documents, monitoring, subject and case report form tracking, drug accountability, data queries, adverse events; developing and managing randomization logistics, namely, randomization envelopes, customized blind breakable drug labelling, code break management and reports, manufacturing of subject- and protocol specific kits using bulk oral and topical medications; drafting clinical study protocols, eCRF Data Fields, eCRF builds, data management plans, database lock, data visualization, statistical analysis plans, statistical reports, full integrated clinical research report...
aest-ethica

General Information


Serial Number97931030
Word MarkAEST-ETHICA
Filing DateThursday, May 11, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, May 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesContract research services for clinical trials, namely, conducting investigator meetings; clinical trial management services, namely, study-specific clinical personnel training programs for investigators and coordinators, investigator meetings
Goods and ServicesContract research services for clinical trials, namely, recruiting investigators, providing strategies for recruitment of participants, screening participants; clinical trial management services, namely, : pre-study document collection and review, site selection, pre-study site visits, initiation visits, monitoring visits, closeout visits, project tracking and monitoring reports, negotiation and administration of investigator grants, labelling, packaging, distribution, coordination and tracking of clinical trial materials, regulatory document processing, central laboratory selection and coordination; clinical trial management services, namely, site and study-specific participant recruitment strategies and programs, namely, contingency strategies and solutions to address specific project challenges, development of all study related documents and materials, namely, study protocols, amendments, case report forms (paper or electronic), informed consent forms, study operations/monitoring manuals in accordance with data management conventions, web-based data listings, namely, adverse events, enrollment status, efficacy endpoints, study newsletters (paper or electronic); management of tracking tools for enrollment, essential documents, monitoring, subject and case report form tracking, drug accountability, data queries, adverse events; clinical trial supplies management services, namely,: customized drug packaging and labelling, randomization (central and site administered) and study supply distribution, developing and managing distribution and storage logistics for all clinical supplies (study drugs and devices, case report forms, study binders, all study related documentation); managing all aspects of study drug reconciliation and inventory and distribution reports; data management services (eCRF Data Fields, eCRF builds, data management plans, database lock, data visualization); Biostatistics services (statistical analysis plans, statistical programming/testing/validation, statistical reports); medical writing services (full integrated clinical research reports, publications, abstracts and manuscripts)
Goods and ServicesContract research services for clinical trials, namely, developing study protocols, designing case report forms; developing complete databases in accordance with strict guidelines, cordinating ethics review submissions, developing and maintaining trial master file (paper or electronic), tracking of study parameters, providing statistical analyses and reporting; development of tracking tools for enrollment, essential documents, monitoring, subject and case report form tracking, drug accountability, data queries, adverse events; developing and managing randomization logistics, namely, randomization envelopes, customized blind breakable drug labelling, code break management and reports, manufacturing of subject- and protocol specific kits using bulk oral and topical medications; drafting clinical study protocols, eCRF Data Fields, eCRF builds, data management plans, database lock, data visualization, statistical analysis plans, statistical reports, full integrated clinical research reports, publications, abstracts and manuscripts

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateSaturday, June 10, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateSaturday, June 10, 2023
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, June 10, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEthica CRO Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKirkland, Quebec H9H3C4
CA

Trademark Events


Event DateEvent Description
Monday, May 15, 2023NEW APPLICATION ENTERED
Saturday, June 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 6, 2024ASSIGNED TO EXAMINER
Tuesday, February 6, 2024NON-FINAL ACTION WRITTEN
Tuesday, February 6, 2024NON-FINAL ACTION E-MAILED
Tuesday, February 6, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 22, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, May 22, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND